Deals of the Week Gets Disruptive

16-11-2013 The IN VIVO BlogComments (0)

Biotechnologyimmatics biotechnologiesRoche

Roche/immatics: People have begun to sit up and take notice of immatics biotechnologies GMBH after the company announced on Nov. 13 a cancer vaccine collaboration with Roche that could lead to the German immunotherapeutics biotech receiving ...

Read more on The IN VIVO Blog

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top